ArticleJournal for immunotherapy of cancer2020

Persistent anti-NY-ESO-1-specific T cells and expression of differential biomarkers in a patient with metastatic gastric cancer benefiting from combined radioimmunotherapy treatment: a case report.

Maysaloun Merhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.